BD completes spinoff of Diabetes Care business as Embecta Corp. (EMBC)

BECTON DICKINSON & CO

Shareholders receive one share of embecta for every five BD shares held as of March 22, 2022.
BD retains no ownership; embecta begins trading on NASDAQ under ticker EMBC.
Two BD directors (Claire Pomeroy, David Melcher) resign to join embecta board; BD board reduced to 11.
embecta issued $200M 6.750% senior secured notes due 2030 to BD; BD exchanged for $199M floating-rate notes.
BD guaranteed embecta credit facility and senior notes; guarantee automatically released upon separation.

item 5.02 item 7.01 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Claire Pomeroy

director

BDX · BECTON DICKINSON & CO

Effective: 2022-04-01
Filed: April 6, 2022, 7:59 PM ET

each of Claire Pomeroy, MD and David F. Melcher has resigned as directors of BD, in each case effective as of April 1, 2022, in connection with the completion of the Separation and the Distribution and their appointment to the board of directors of embecta.

Departed

David Melcher

director

BDX · BECTON DICKINSON & CO

Effective: 2022-04-01
Filed: April 6, 2022, 7:59 PM ET

each of Claire Pomeroy, MD and David F. Melcher has resigned as directors of BD, in each case effective as of April 1, 2022, in connection with the completion of the Separation and the Distribution and their appointment to the board of directors of embecta.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Claire Pomeroy resigned as director at BECTON DICKINSON & CO.

Action: resigned
Role: director

Exact text from the filing

each of Claire Pomeroy, MD and David F. Melcher has resigned as directors of BD, in each case effective as of April 1, 2022, in connection with the completion of the Separation and the Distribution and their appointment to the board of directors of embecta.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

David Melcher resigned as director at BECTON DICKINSON & CO.

Action: resigned
Role: director

Exact text from the filing

each of Claire Pomeroy, MD and David F. Melcher has resigned as directors of BD, in each case effective as of April 1, 2022, in connection with the completion of the Separation and the Distribution and their appointment to the board of directors of embecta.

View on SEC.gov

BECTON DICKINSON & CO filing history →

Source: SEC EDGAR

accession 0001193125-22-097657

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.